Jane Street’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-282,478
| Closed | -$360K | – | 6306 |
|
|
2023
Q3 | $360K | Buy |
+282,478
| New | +$360K | ﹤0.01% | 3892 |
|
|
2023
Q1 | – | Sell |
-38,984
| Closed | -$20.7K | – | 6500 |
|
|
2022
Q4 | $20.7K | Sell |
38,984
-24,231
| -38% | -$12.8K | ﹤0.01% | 5063 |
|
|
2022
Q3 | $46K | Buy |
+63,215
| New | +$46K | ﹤0.01% | 5122 |
|
|
2022
Q2 | – | Sell |
-63,346
| Closed | -$130K | – | 6528 |
|
|
2022
Q1 | $130K | Buy |
63,346
+18,541
| +41% | +$38.1K | ﹤0.01% | 4901 |
|
|
2021
Q4 | $129K | Sell |
44,805
-29,879
| -40% | -$86K | ﹤0.01% | 4575 |
|
|
2021
Q3 | $316K | Buy |
74,684
+49,185
| +193% | +$208K | ﹤0.01% | 3900 |
|
|
2021
Q2 | $136K | Sell |
25,499
-4,932
| -16% | -$26.3K | ﹤0.01% | 4637 |
|
|
2021
Q1 | $142K | Buy |
+30,431
| New | +$142K | ﹤0.01% | 4438 |
|
|
2020
Q3 | – | Sell |
-138,145
| Closed | -$466K | – | 4642 |
|
|
2020
Q2 | $466K | Buy |
+138,145
| New | +$466K | ﹤0.01% | 2604 |
|
|
2019
Q4 | – | Sell |
-11,352
| Closed | -$86K | – | 4044 |
|
|
2019
Q3 | $86K | Sell |
11,352
-6,653
| -37% | -$50.4K | ﹤0.01% | 3200 |
|
|
2019
Q2 | $244K | Buy |
+18,005
| New | +$244K | ﹤0.01% | 2956 |
|
|
2019
Q1 | – | Sell |
-12,267
| Closed | -$36K | – | 3893 |
|
|
2018
Q4 | $36K | Sell |
12,267
-23,288
| -65% | -$68.3K | ﹤0.01% | 3053 |
|
|
2018
Q3 | $290K | Buy |
35,555
+10,967
| +45% | +$89.5K | ﹤0.01% | 2820 |
|
|
2018
Q2 | $239K | Buy |
+24,588
| New | +$239K | ﹤0.01% | 2786 |
|